Your browser does not support JavaScript!
COVID-19 : Découvrez les Plans de Continuité d’Activité des entreprises de la biotechnologies

Matières premières

351 entreprises et organismes intervenants dans le domaine 'Matières premières', classés par activité.

Rejoignez la communauté
Trouvez du matériel
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 1 semaine
Skyhawk Therapeutics boosts Merck collab pact with added targets, upfront and biobucks
Merck has decided to double down on its research pact with startup Skyhawk Therapeutics as it expands the deal to now also cover autoimmune and metabolic diseases....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Il y a 3 semaines
Merck, slower than its peers, edges into COVID-19 fight
Almost all of Merck’s Big Pharma peers have either on their own or, increasingly, with a partner, geared up to fight the good fight against COVID-19....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 28/04/2020
Merck joins Seattle consortium to uncover the coronavirus’ molecular workings
Merck & Co. has begun working with the non-profit Institute for Systems Biology and a consortium of companies to investigate the molecular mechanisms behind the novel coronavirus, in a bid to...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 16/04/2020
Lawrence lands Cardurion CEO job after helping ArQule to Merck buyout
Peter Lawrence has taken up the CEO job at Cardurion Pharmaceuticals, a Takeda-partnered biotech that is moving a heart failure drug through the clinic. Lawrence landed the gig on the strength of a...
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 30/03/2020
ACC: Bayer and Merck's vericiguat leads off virtual meeting with positive phase 3 heart failure data
After teasing positive top-line results last November, a deeper dive into Merck & Co. and Bayer’s heart failure drug vericiguat helped kick off this year’s scientific meeting of the American...
www.fiercebiotech.com
ABBOTT
est cité dans une actualité de FierceBiotech
Le 30/03/2020
Abbott to ship portable, 5-minute coronavirus tests nationwide
Abbott is launching a rapid coronavirus test able to deliver positive results in as little as five minutes from a tabletop box the size of a small toaster oven....
www.fiercebiotech.com
ABBOTT
est cité dans une actualité de FierceBiotech
Le 20/03/2020
With new FDA approval, Abbott sets goal of shipping 1 million coronavirus tests per week
Abbott received an emergency use authorization from the FDA for its COVID-19 diagnostic, and announced goals to ramp up U.S. production to 1 million tests per week by the end of March....
www.fiercebiotech.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 18/03/2020
Merck hits goal in cough phase 3 but yet to quash tolerability concern
Merck has linked gefapixant to statistically significant improvements in chronic cough patients in two phase 3 trials. The results cement Merck’s status as the front-runner in the race to develop a...
www.fiercebiotech.com
BIOMERIEUX
est cité dans une actualité de L'Usine Nouvelle
Le 28/02/2020
BioMérieux travaille sur deux tests de détection du coronavirus Covid-19
Le spécialiste français des solutions de diagnostic a lancé deux programmes pour la mise au point de tests pour la détection du Covid-19, avec une... - L'Usine Santé
www.usinenouvelle.com
MERCK MILLIPORE
est cité dans une actualité de FierceBiotech
Le 19/02/2020
'Closer to the science': Why Amgen vets Harper and Seidenberg set up their own VC shop
After 17 years at Amgen, head of R&D Sean Harper was ready to get closer to the science. He reunited with his former colleague from Merck and Amgen, Beth Seidenberg, in Los Angeles and set up...
www.fiercebiotech.com
Charger plus d'actualités